DAWN DRAZEK: Open Payments
NPI 1710396841 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,388 in 38 payments from 7 companies in 2025. Trend: 2023 $423 · 2024 $4,130 · 2025 $9,388
Consulting: $2,890Speaker / faculty: $2,315Travel & lodging: $2,120Food & beverage: $2,062
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $5,113 |
| Ipsen Biopharmaceuticals, Inc | 10 | $3,222 |
| Madrigal Pharmaceuticals | 4 | $411 |
| GlaxoSmithKline, LLC. | 2 | $312 |
| Novo Nordisk Inc | 3 | $254 |
| Intercept Pharmaceuticals, Inc. | 1 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 |
Products named: Livdelzi, Bylvay, IQIRVO, REZDIFFRA, Wegovy, Yeztugo, Vemlidy, OCALIVA.
Industry payments across NC — which companies pay providers there.
